| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.048 | 0.8 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |